An Introduction to Molecular Biotechnology: Fundamentals, Methods and Applications

ISBN 10: 3527344144 / ISBN 13: 9783527344147

Edité par John Wiley & Sons, 2021

A propos de cet article

pp. 566.

N° de réf. du vendeur 369583403

Détails bibliographiques

• Titre: An Introduction to Molecular Biotechnology: Fundamentals, Methods and Applications
• Éditeur: John Wiley & Sons
• Date de parution: 2021
• Langue: anglais
• ISBN à 10 chiffres: 3527344144
• ISBN à 13 chiffres: 9783527344147
• Reliure: Couverture souple
• Édition: 3ème Édition
• État de l'article: New

A propos de ce titre

Synopsis

Completely updated in line with the rapid progress made in the field, this new edition of the highly-praised textbook addresses powerful new methods and concepts in biotechnology, such as genome editing, reprogrammed stem cells, and personalized medicine.
An introduction to the fundamentals in molecular and cell biology is followed by a description of standard techniques, including purification and analysis of biomolecules, cloning techniques, gene expression systems, genome editing methods, labeling of proteins and in situ-techniques, standard and high resolution microscopy. The third part focuses on key areas in research and application, ranging from functional genomics, proteomics and bioinformatics to drug targeting, recombinant antibodies and systems biology. The final part looks at the biotechnology industry, explaining intellectual property issues, legal frameworks for pharmaceutical products and the interplay between start-up and larger companies. The contents are beautifully illustrated throughout, with hundreds of full color diagrams and photographs.
Provides students and professionals in life sciences, pharmacy and biochemistry with everything they need to know about molecular biotechnology.

À propos de l?auteur

Michael Wink studied biology and chemistry in Bonn and was awarded his doctorate from TU Braunschweig in 1980. After gaining his lecturing qualification in 1984/1985, he was awarded a Heisenberg grant by the German Research Council to work at the Max Planck Institute for Breeding Research in Cologne and from then at the Gene Center of Ludwig-Maximilians University in Munich. Following a chair for Pharmaceutical Biology at Mainz University in 1988, he accepted the post of Professor for Pharmaceutical Biology at the University of Heidelberg one year later. His areas of interest include pharmaceutical research, molecular biotechnology, and medicinal plants, as well as research into natural products and evolution.